Published in
PAGEpress, Mediterranean Journal of Hematology and Infectious Diseases, 1(13), p. e2021054, 2021
Links
Tools
Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient
Journal article published in 2021 by
Gabriele Magliano,
Annarosa Cuccaro 
,
Francesco D'Alo',
Elena Maiolo,
Silvia Bellesi,
Stefan Hohaus,
Andrea Bacigalupo,
Livio Pagano
,
Francesco D'Alo',
Elena Maiolo,
Silvia Bellesi,
Stefan Hohaus,
Andrea Bacigalupo,
Livio Pagano
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
We discuss the case of a 74-year old male patient with mantle cell lymphoma, who faced severe CMV infection after the fifth cycle of first-line chemo-immunotherapy with a dose-reduced bendamustine and rituximab regimen.